Are vaccines making a comeback in non-small-cell lung cancer?
Nemunaitis
John J
JJ
D000951:Antigens, Neoplasm / Q000276:immunology; D014408:Biomarkers, Tumor / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods; D008081:Liposomes; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000276:immunology / Q000627:therapeutic use; D009363:Neoplasm Proteins / Q000276:immunology; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D016207:Cytokines; C518273:L-BLP25; D008081:Liposomes; C072013:MAGEA3 protein, human; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; C514428:belagenpumatucel L